Zixia Lin
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
-
- Peptidase Inhibition and Analysis
Papers in
-
- Ubiquitin and proteasome pathways 2
- Protein Interaction Studies and Fluorescence Analysis 1
- Surgery 4
- Paraquat toxicity studies and treatments 1
- Co-authors
- Zhiwei Wang (2 shared papers)Gang Chen (5 shared papers)Yunfeng Shan (3 shared papers)Xiaoli Hu (1 shared paper)Tuo Deng (3 shared papers)Zhengping Yu (3 shared papers)Wen Ye (2 shared papers)Zhehao Shi (2 shared papers)
- Journals
- Cell Death Discovery (1 paper)Clinical and Translational Medicine (1 paper)Biomedical Chromatography (1 paper)American Journal of Cancer Research (1 paper)Cancer Medicine (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Zixia Lin
13 papers receiving 281 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 55
- Oncology 73
- Pulmonary and Respiratory Medicine 72
- Molecular Biology 127
- Pharmacology 12
Countries citing papers authored by Zixia Lin
This map shows the geographic impact of Zixia Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zixia Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zixia Lin more than expected).
Fields of papers citing papers by Zixia Lin
This network shows the impact of papers produced by Zixia Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zixia Lin. The network helps show where Zixia Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Zixia Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 73 | |
| 2 | 2021 | 45 | |
| 3 | 2021 | 34 | |
| 4 | Emerging role of PD-L1 modification in cancer immunotherapy. | 2021 | 32 |
| 5 | 2020 | 27 | |
| 6 | 2017 | 20 | |
| 7 | 2022 | 16 | |
| 8 | 2021 | 14 | |
| 9 | 2022 | 13 | |
| 10 | 2017 | 4 | |
| 11 | 2016 | 2 | |
| 12 | [Histamine release properties of human basophils in response to various stimuli]. | 2005 | 2 |
| 13 | 2017 | 1 |
About Zixia Lin
Zixia Lin is a scholar working on Molecular Biology, Surgery, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 13 papers that have together received 283 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (2 papers), Omental and Epiploic Conditions (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper), Ferroptosis and cancer prognosis (1 paper), Paraquat toxicity studies and treatments (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Sesquiterpenes and Asteraceae Studies (1 paper) and Protein Interaction Studies and Fluorescence Analysis (1 paper). The work is most often cited by research in Cancer Research (55 citations), Oncology (73 citations), Pulmonary and Respiratory Medicine (72 citations), Molecular Biology (127 citations) and Pharmacology (12 citations). Zixia Lin has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Zhiwei Wang, Gang Chen, Yunfeng Shan, Xiaoli Hu, Tuo Deng, Zhengping Yu, Wen Ye, Zhehao Shi, Tan Zhang and Jiangtao Yu. Their work appears in journals such as Cell Death Discovery, Clinical and Translational Medicine, Biomedical Chromatography, American Journal of Cancer Research and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.